Instagram and Snapchat have been found to be most detrimental to young people’s mental health. But can (and should) Instagram shield youth from cosmetic surgery procedure posts?
When should lasers be used to treat melasma? Mildred López Piñeiro, M.D. provides her insight in our new column on energy devices.
By the end of a three-day weekend, five of the teams at Hacking Dermatology's 2019 Hackathon walked away with $5,000 each. Learn more about the collaboration that took place and the solutions each team developed to solve pressing problem areas in dermatology.
Dr. Wever discusses the prevalence of BDD in the aesthetic practice and how to identify the psychological disorder.
Many patients living with hyperhidrosis do so silently, meaning the condition is often left untreated. It's up to dermatologists start the conversation about available treatments when they notice patients’ symptoms, say this expert.
Clinical trials investigating the efficacy of biologics in treating this condition at Stage 2 and Stage 3 are growing in number and should be considered a front-line treatment option, says this expert.
Research shows activating LGR6+ stem cells with defensins repopulates the epidermis with fresh keratinocytes for visible improvement.
Stay up-to-date on the most recent clinical advances in atopic dermatitis.
Brett Coldiron, M.D., offers insight on how recent legislative and regulatory changes may impact your practice.
A growing body of evidence supports treating melasma with systemic or intradermal tranexamic acid. But melasma patients often relapse when they stop taking the antifibrinolytic agent, and research on tranexamic acid’s long-term efficacy and safety is limited.